Should you buy BEAM stock?

Last updated:

Based on market data through , StockInvest.us rates Beam Therapeutics Inc. (BEAM) as a Sell Candidate with a technical score of -1.72 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Sell signal since
  • Price since signal Up 0.78%
  • 3-month trend forecast Down 7.53%
  • Sell Candidate -1.72
AI Analysis AI Analysis of BEAM AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BEAM to Watchlist?
Some Reasons Why To Add BEAM:
  • Low bankruptcy risk (Altman Z-Score: 4.27)
  • Highly efficient cash conversion (104% FCF/OCF ratio)
  • +58.9% price growth over the last year
PDF

Beam Therapeutics Inc. stock price down 0.728% on Monday
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Aug 05, 2026 Gain 0.78%

The Beam Therapeutics Inc. stock price fell by -0.728% on the last day (Monday, 10th Aug 2026) from $27.48 to $27.28. During the last trading day the stock fluctuated 2.36% from a day low at $27.11 to a day high of $27.75. The price has risen in 6 of the last 10 days and is up by 8.82% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -56 thousand shares and in total, 1 million shares were bought and sold for approximately $34.16 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -7.53% during the next 3 months and, with a 90% probability hold a price between $21.84 and $33.99 at the end of this 3-month period.

BEAM Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Beam Therapeutics Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $30.29. On a fall, the stock will find some support from the short-term average at $26.98. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Tuesday, August 04, 2026, and so far it has fallen -3.77%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Beam Therapeutics Inc. stock

Beam Therapeutics Inc. finds support from accumulated volume at $26.33 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.640 between high and low, or 2.36%. For the last week, the stock has had daily average volatility of 5.34%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BEAM) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Beam Therapeutics Inc. to open at $27.38, and during the day (based on 14 day Average True Range), to move between $26.42 and $28.14, which gives a possible trading interval of +/-$1.71 (+/-6.49%) up or down from last closing price. If Beam Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 6.49% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $26.33 (3.48%) than the resistance at $28.39 (4.07%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Beam Therapeutics Inc. stock A Buy?

Beam Therapeutics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.722 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $27.38 ( 0.367%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BEAM Performance

Trading levels for BEAM

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 28.02 2.71%
R2 27.78 1.82%
R1 27.62 1.26%
Price 27.28
S1 27.14 -0.530%
S2 26.98 -1.08%
S3 26.74 -1.98%

Accumulated Volume Support & Resistance Levels

Level Price
R3 33.20 21.70%
R2 32.84 20.38%
R1 28.39 4.07%
Price 27.28
S1 26.33 -3.48%
S2 26.29 -3.63%
S3 25.91 -5.02%

BEAM Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jan 22, 2014 Feb 04, 2014 Mar 03, 2014 $0.225 0%
2 Sep 19, 2013 Nov 04, 2013 Dec 02, 2013 $0.225 0%
3 Jul 31, 2013 Aug 12, 2013 Sep 03, 2013 $0.225 0%
4 Apr 24, 2013 May 06, 2013 Jun 03, 2013 $0.225 0%
5 Jan 28, 2013 Feb 04, 2013 Mar 01, 2013 $0.225 0%

FAQ

What is the symbol for Beam Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Beam Therapeutics Inc. is BEAM and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Beam Therapeutics Inc. Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Beam Therapeutics Inc. (BEAM) as a Sell Candidate with a technical score of -1.72 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Sell signal began on Aug 05, 2026, the price has risen 0.78%. The current 3-month trend forecast projects a fall of 7.53%.

How to buy Beam Therapeutics Inc. Stock?
Beam Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Beam Therapeutics Inc. Stock.

What's the current price of Beam Therapeutics Inc. Stock?
As of the end of day on the Aug 10, 2026, the price of an Beam Therapeutics Inc. (BEAM) share was $27.28.

What is the 52-week high and low for Beam Therapeutics Inc. Stock?
The 52-week high for Beam Therapeutics Inc. Stock is $38.26 and the 52-week low is $15.60.

What is the market capitalization of Beam Therapeutics Inc. Stock?
As of the Aug 10, 2026, the market capitalization of Beam Therapeutics Inc. is 2.807B.
Click to get the best stock tips daily for free!
ABOUT BEAM THERAPEUTICS INC.
Beam Therapeutics
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia; and BEAM-...
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE